CANBERRA, April 9 (Reuters) - Australia's most populous state said on Friday it has temporarily suspended the use of AstraZeneca (NASDAQ:AZN)'s AZN.L COVID-19 vaccine following updated advice from the federal government.
New South Wales said inoculations using the AstraZeneca vaccine will be paused for a few hours while it updates its advice to patients allowing them to give informed consent.